Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kinnimulki Vijayachandra"'
Publikováno v:
Molecular Carcinogenesis. 48:181-186
TGFbeta1 acts as a potent negative regulator of the cell cycle and tumor suppressor in part through induction of cyclin dependent kinase inhibitors p15(ink4b), p21, and p57. We previously showed that primary mouse epidermal keratinocytes (MEK) expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52e9d91c77b7ff98fef6361bbd78165b
https://doi.org/10.1002/mc.20472
https://doi.org/10.1002/mc.20472
Autor:
Craig D. Woodworth, Evan Michael, Henry Hennings, Kinnimulki Vijayachandra, Stuart H. Yuspa, Adam B. Glick, Laura Smith
Publikováno v:
Carcinogenesis. 25:1771-1778
The multistage evolution of squamous skin tumors induced by chemical or viral carcinogens on mice from different genetic backgrounds has been a valuable model to define low penetrance loci that determine cancer susceptibility or resistance. Susceptib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7972e7168f777a54cae7f40105d6b3a
https://doi.org/10.1093/carcin/bgh170
https://doi.org/10.1093/carcin/bgh170
Autor:
Rajani Battu, Prasannakumar Basayya Shirol, M. E. Ravinandan, Harsha Karur Rajasimha, Preveen Ramamoorthy, Duraiswamy Navaneetham, Ishwar C. Verma, Rajashree Devarakonda, Madhuri Hegde, Sudha Srinivasan, Imran A. Babar, Sangeeta Barde, Usha Kini, Vijay Chandru, Ramani Ramchandran, Kinnimulki Vijayachandra, Jimmy Cheng-Ho Lin, Katta M. Girisha, Kasturi Haldar
SummaryIn order to address the unmet needs and create opportunities that benefit patients with rare disease in India, a group of volunteers created a not-for-profit organization named Organization for Rare Diseases India (ORDI; www.ordindia.org). ORD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350e5279b126700119583e693e876366
https://europepmc.org/articles/PMC7044965/
https://europepmc.org/articles/PMC7044965/
Publikováno v:
Molecular carcinogenesis. 48(3)
TGFbeta1 acts as a potent negative regulator of the cell cycle and tumor suppressor in part through induction of cyclin dependent kinase inhibitors p15(ink4b), p21, and p57. We previously showed that primary mouse epidermal keratinocytes (MEK) expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60cd877dd6cec4e95769f12160880d14
https://pubmed.ncbi.nlm.nih.gov/18655107
https://pubmed.ncbi.nlm.nih.gov/18655107
Publikováno v:
Transforming Growth Factor-β in Cancer Therapy, Volume I ISBN: 9781588297143
The multistep nature of cancer derives from the stepwise activation and loss of signaling pathways, which govern the behavior of the tumor cell, its interaction with neighboring cells, local micro-environment, and organism. Rather than acting indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3984a231a1bc8899abb59e928c6a934
https://doi.org/10.1007/978-1-59745-292-2_19
https://doi.org/10.1007/978-1-59745-292-2_19
Publikováno v:
Cancer research. 63(13)
Transforming growth factor beta (TGF-beta) is a growth-inhibitory cytokine for epithelial cells. In the mouse multistage skin carcinogenesis model, defects in TGF-beta 1 signaling reduce senescence in vitro and accelerate malignant progression in viv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a83eb05f22d617621fb036b1dbd26141
https://pubmed.ncbi.nlm.nih.gov/12839923
https://pubmed.ncbi.nlm.nih.gov/12839923
Autor:
Xin Liu, Ilysa Diamond, Kinnimulki Vijayachandra, Ervind Bhogte, Valarie Alexander, Adam B. Glick
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 98(16)
To study the role of transforming growth factor type β1 (TGFβ1) in epidermal growth control and disease, we have generated a conditional expression system by using the bovine keratin 5 promoter to drive expression of the tetracycline-regulated tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c170b1e3ba02ee15ae914320b4f2baba
https://pubmed.ncbi.nlm.nih.gov/11481479
https://pubmed.ncbi.nlm.nih.gov/11481479
Publikováno v:
The Journal of biological chemistry. 276(22)
Inactivation of the transforming growth factor beta (TGFbeta)-signaling pathway and gene silencing through hypermethylation of promoter CpG islands are two frequent alterations in human and experimental cancers. Here we report that nonneoplastic TGFb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ffe495b882df1e03600fb0076f6797
https://pubmed.ncbi.nlm.nih.gov/11262404
https://pubmed.ncbi.nlm.nih.gov/11262404
Autor:
Tremain, Ryan, Marko, Melissa, Kinnimulki, Vijayachandra, Ueno, Hikaru, Bottinger, Erwin, Glick, Adam
Publikováno v:
Oncogene; 3/23/2000, Vol. 19 Issue 13, p1698, 12p
Autor:
Tremain, Ryan, Marko, Melissa, Kinnimulki, Vijayachandra, Ueno, Hikaru, Bottinger, Erwin, Glick, Adam
Publikováno v:
Oncogene. 3/23/2000, Vol. 19 Issue 13, p1698. 12p.